You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

METAPROTERENOL SULFATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for metaproterenol sulfate and what is the scope of patent protection?

Metaproterenol sulfate is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Muro, Cosette, G And W Labs Inc, Genus, Morton Grove, Am Therap, Heritage Pharma, Strides Pharma, Usl Pharma, and Watson Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for metaproterenol sulfate.

Summary for METAPROTERENOL SULFATE
US Patents:0
Tradenames:3
Applicants:17
NDAs:36
Drug Master File Entries: 5
Raw Ingredient (Bulk) Api Vendors: 58
Patent Applications: 2,557
What excipients (inactive ingredients) are in METAPROTERENOL SULFATE?METAPROTERENOL SULFATE excipients list
DailyMed Link:METAPROTERENOL SULFATE at DailyMed
Medical Subject Heading (MeSH) Categories for METAPROTERENOL SULFATE

US Patents and Regulatory Information for METAPROTERENOL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nephron METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 071855-001 Jul 14, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt METAPROTERENOL SULFATE metaproterenol sulfate SOLUTION;INHALATION 075586-001 May 30, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharma METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 072520-001 Mar 30, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Usl Pharma METAPROTERENOL SULFATE metaproterenol sulfate TABLET;ORAL 071014-001 Jan 25, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for METAPROTERENOL SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ALUPENT metaproterenol sulfate SYRUP;ORAL 017571-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate AEROSOL, METERED;INHALATION 016402-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate SOLUTION;INHALATION 017659-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim ALUPENT metaproterenol sulfate TABLET;ORAL 015874-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.